|
ERICH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.640630E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.684000E-01 |
| Normal-vs-Stage2 |
7.009200E-01 |
| Normal-vs-Stage3 |
1.859660E-03 |
| Normal-vs-Stage4 |
8.864600E-03 |
| Stage1-vs-Stage2 |
7.606200E-01 |
| Stage1-vs-Stage3 |
2.237100E-04 |
| Stage1-vs-Stage4 |
3.284300E-03 |
| Stage2-vs-Stage3 |
9.045700E-02 |
| Stage2-vs-Stage4 |
1.374960E-01 |
| Stage3-vs-Stage4 |
8.346200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.805600E-02 |
| Normal-vs-AfricanAmerican |
2.762800E-01 |
| Normal-vs-Asian |
2.940200E-01 |
| Caucasian-vs-AfricanAmerican |
1.433860E-02 |
| Caucasian-vs-Asian |
1.515030E-01 |
| AfricanAmerican-vs-Asian |
4.664200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.081800E-02 |
| Normal-vs-Female |
8.475600E-01 |
| Male-vs-Female |
1.104400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.257400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.696400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.201600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.378600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.465200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.206570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.883200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.264400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.687200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.120000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.023700E-03 |
| Normal-vs-Grade 2 |
5.988800E-01 |
| Normal-vs-Grade 3 |
1.077640E-01 |
| Normal-vs-Grade 4 |
1.391130E-04 |
| Grade 1-vs-Grade 2 |
1.236050E-03 |
| Grade 1-vs-Grade 3 |
9.437600E-04 |
| Grade 1-vs-Grade 4 |
1.68060000027559E-07 |
| Grade 2-vs-Grade 3 |
1.585580E-01 |
| Grade 2-vs-Grade 4 |
1.046620E-04 |
| Grade 3-vs-Grade 4 |
5.676900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.979400E-01 |
| Normal-vs-ccB subtype |
8.299000E-03 |
| ccA subtype-vs-ccB subtype |
1.617760E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.356200E-02 |
| Normal-vs-N1 |
2.016400E-02 |
| N0-vs-N1 |
2.341800E-01 |
|
|
